Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of … – GlobeNewswire (press release)
GlobeNewswire (press release) |
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of …
GlobeNewswire (press release) Lindsay A. Rosenwald, M.D., Fortress Biotech’s Chairman, President and Chief Executive Officer, said, “Dr. Gao is a world-renowned AAV gene therapy researcher who has made significant contributions to the development of safer and more effective AAV … |
|
Molecular Assemblies Expands Leadership Team with Appointment of Vice President of Chemistry and Biochemistry
Markets Insider Molecular Assemblies, Inc. is a San Diego-based company focused on developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature … |
pharmaphorum |
Prokarium raises $10m for ‘game changer’ synthetic bio vaccines
pharmaphorum UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation of vaccines, which could be taken orally, and not have to be kept in a refrigerator. The new funding will allow Prokarium to … Prokarium Secures $10 Million for Clinical Development of Revolutionary Thermostable VaccinesTechnology Networks Prokarium Secures $10 Million Investment from Saudi, Swedish and Korean Investors for Clinical Development of …Business Wire (press release) |